Amarantus Therapeutics Secures $1,299,327 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e29ae5d9-b82d-467f-aa27-5e8dd0903214
Date
9/3/2013
Company Name
Amarantus Therapeutics
Mailing Address
675 Almanor Avenue Sunnyvale, CA 94085
Company Description
The company is developing first-in-class disease–modifying treatments that address the underlying cause of cell death associated with a wide range of diseases.
Website
http://www.amarantustherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$1,299,327
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
M&A Terms
Venture Investor
Undisclosed